Remember
 
 
Watch for Reactions to Your Posts or React Below to Other's Posts. Discover Stocks and Market Data.
     
 

December 26, 2007

SpeculatingStocks.com Stock Pick: Neuralstem, Inc. (CUR)

Stock Price: $3.19


Neuralstem, Inc., a biotechnology company, engages in developing and commercializing treatments based on transplanting human neural stem cells. The company uses its proprietary human neural stem cell technology to create biotherapeutic products for the treatment of central nervous system diseases and various neurodegenerative conditions, and for the regenerative repair of acute diseases.

CUR was exclusively licensed the "Spinal Multisegmental Cell and Drug Delivery System," invented by Dr. Martin Marsala at the University of California, San Diego (UCSD). The system provides a unique method for delivering spinal cord stem cells horizontally along the length of the spinal cord.

Last week, CUR entered into a clinical trial research agreement with the University of Pennsylvania aimed at treating patients with Ischemic Spastic Paraplegia, a form of spinal cord paralysis.

We believe stem cell stocks will receive much more attention in 2008 than they have in 2007 with the 2008 general election approaching. CUR has a chance to find a cure for spinal cord paralysis using stem cells.

CUR received a significant amount of attention in today's trading session, moving up over 20% on over 24 times average volume.

 
     
Untitled Document